Hai-xiang Sun
Key Laboratory Of Carcinogenesis And Cancer Invasion
Zhongshan, China
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: March 30, 2026
Anlotinib potentiates anti-PD1 immunotherapy via transferrin receptor-dependent CD8+ T-cell infiltration in hepatocellular carcinoma.
Journal: Clinical and translational medicine
Published: February 21, 2024
WDR4/TRIM28 is a novel molecular target linked to lenvatinib resistance that helps retain the stem characteristics in hepatocellular carcinomas.
Journal: Cancer letters
Published: January 09, 2023
CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor.
Journal: Cell discovery
Published: November 17, 2022
Differential network analysis depicts regulatory mechanisms for hepatocellular carcinoma from diverse backgrounds.
Journal: Future oncology (London, England)
Published: November 16, 2019
Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 05, 2018
New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer.
Journal: Journal of cellular biochemistry
Published: January 22, 2018
Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
Journal: Cell death & disease
Published: April 12, 2017
Last Updated: 09/26/2026